Jiabao He1, Dinesh Tryambake1,
Michael J. Firbank2, John T. OBrien2,
1Institute of Cellular Medicine, Newcastle
University, Newcastle upon Tyne, Tyne and Wear, United Kingdom; 2Institute
for Ageing and Health, Newcastle University, Newcastle upon Tyne, Tyne and
Wear, United Kingdom
CBF
determines brain tissue metabolic supply and is compromised in chronic hypertension
which alters autoregulatory function.
Blood pressure (BP) lowering therapy has clear clinical benefit but
may risk inducing hypoperfusion.
Optimal target BP in older subjects with hypertension is unclear,
although guidelines recommend target BP of <130/85 mmHg and <140/80
mmHg for patients with and without previous vascular events respectively. We
used ASL to determine the effect of usual (<140/85 mmHg) and intensive
(<130/80 mmHg) BP lowering on CBF in older hypertensive subjects and
demonstrate that intensive BP lowering increases CBF compared to usual BP
lowering therapy.